Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$3.99 - $17.73 $52,504 - $233,309
-13,159 Closed
0 $0
Q3 2020

Jun 26, 2023

BUY
$11.19 - $16.92 $147,249 - $222,650
13,159 New
13,159 $222,000
Q2 2020

May 24, 2024

BUY
$4.42 - $12.66 $58,162 - $166,592
13,159 New
13,159 $148 Million
Q2 2020

Jun 26, 2023

BUY
$4.42 - $12.66 $58,162 - $166,592
13,159 New
13,159 $147,000
Q2 2020

Mar 22, 2023

BUY
$4.42 - $12.66 $58,162 - $166,592
13,159 New
13,159 $147,000
Q2 2020

Aug 14, 2020

BUY
$4.42 - $12.66 $58,162 - $166,592
13,159 New
13,159 $148,000

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $58M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.